Pharmacogenomics and pharmacogenetics of hypertension: Update and perspectives - The adducin paradigm

Journal of the American Society of Nephrology

Volumn 17, Issue SUPPL. 2, 2006, Pages

  Manunta, Paolo ^a,b   Bianchi, Giuseppe ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADDUCIN; ANTIHYPERTENSIVE AGENT; CYTOSKELETON PROTEIN; DIURETIC AGENT; PROTEIN SUBUNIT;

ADD1 GENE; ADD2 GENE; ADD3 GENE; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CHROMOSOMAL LOCALIZATION; CONFERENCE PAPER; FOLLOW UP; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENOME ANALYSIS; GENOTYPE ENVIRONMENT INTERACTION; HEART INFARCTION; HUMAN; HYPERTENSION; KIDNEY TUBULE ABSORPTION; PHARMACOGENETICS; PHARMACOGENOMICS; PRIORITY JOURNAL; RAT STRAIN; SODIUM ABSORPTION; STROKE;

EID: 33645473132     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005121346     Document Type: Conference Paper

References (48)

1. Bianchi G, Staessen JA, Ferrari P: Pharmacogenomics of primary hypertension: The lesson from the past to look toward the future. Pharmacogenomics 4: 279-296, 2003
2. Roses AD: Pharmacogenetics and drug development: The path to safer and more effective drugs. Nat Rev Genet 5: 645-656, 2004
3. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ: National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. Hypertension 42: 1206-1252, 2003
4. European Society of Hypertension-European Society of Cardiology Guidelines Committee: 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 21: 1011-1053, 2003
5. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, Sever PS, Thorn SM; BHS guidelines working party, for the British Hypertension Society: British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): Summary. BMJ 328: 634-640, 2004
6. Staessen JA, Wang JG, Thijs L: Cardiovascular prevention and blood pressure reduction: A quantitative overview updated until 1 March 2003. J Hypertens 21: 1055-1076, 2003
7. Blood Pressure Lowering Treatment Trialists' Collaboration: Effects of different blood-pressure-lowering regimens on major cardiovascular events: Results of prospectively-designed overviews of randomised trials. Lancet 362: 1527-1535, 2003
8. Dusing R, Weisser B, Mengden T, Vetter H: Changes in antihypertensive therapy: The role of adverse effects and compliance. Blood Press 7: 313-315, 1998
9. Meilen PB, Herrington DM: Pharmacogenomics of blood pressure response to antihypertensive treatment. J Hypertens 23: 1311-1325, 2005
10. Page GP, George V, Go RC, Page PZ, Allison DB: "Are we there yet?" Deciding when one has demonstrated specific genetic causation in complex diseases and quantitative traits. Am J Hum Genet 73: 711-719, 2003
11. Cardon LR, Palmer LJ: Population stratification and spurious allelic association. Lancet 361: 598-604, 2003
12. Glazier AM, Nadeau JH, Aitman TJ: Finding genes that underline complex traits. Science 298: 2345-2349, 2002
13. Bianchi G, Cusi D: Association and linkage analysis of alpha-adducin polymorphism: Is the glass half full or half empty? Am J Hypertens 13: 739-743, 2000
14. Tabor HK, Risch NJ, Myers RM: Candidate-gene approaches for studying complex genetic traits: Practical considerations. Nat Rev Genet 3: 391-396, 2002
15. Verdecchia P, Angeli F, Reboldi GP, Gattobigio R: New-onset diabetes in treated hypertensive patients. Curr Hypertens Rep 7: 174-179, 2005
16. Bianchi G: Genetic variations of tubular sodium reabsorption leading to "primary" hypertension: From gene polymorphism to clinical symptoms. Am J Physiol Regul Integr Comp Physiol 289: R1536-R1549, 2005
17. Matsuoka Y, Li X, Bennett V: Adducin: Structure, function and regulation. Cell Mol Life Sci 57: 884-895, 2000
18. Joshi R, Gilligan DM, Otto E, McLaughlin T, Bennett V: Primary structure and domain organization of human alpha and beta adducin. J Cell Biol 115: 665-675, 1991
19. Matsuoka Y, Hughes CA, Bennett V: Adducin regulation. Definition of the calmodulin-binding domain and sites of phosphorylation by protein kinases A and C. J Biol Chem 271: 25157-25166, 1996
20. Cusi D, Barlassina C, Azzani T, Casari G, Citterio L, Devoto M, Glorioso N, Lanzani C, Manunta P, Righetti M, Rivera R, Stella P, Troffa C, Zagato L, Bianchi G: Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet 349: 1353-1357, 1997
21. Tripodi MG, Valtorta F, Torielli L, Chieregatti E, Salardi S, Trusolino L, Menegon A, Ferrari P, Marchisio PC, Bianchi G: Hypertension-associated point mutations in the adducing alpha and beta subunits affect actin cytoskeleton and ion transport. J Clin Invest 97: 2815-2822, 1996
22. Ferrandi M, Salardi S, Tripodi G, Barassi P, Rivera R, Manunta P, Goldshleger R, Ferrari P, Bianchi G, Karlish SJ: Evidence for an interaction between adducin and Na(+)-K(+)-ATPase: Relation to genetic hypertension. Am J Physiol 19 99277: H1338-H1349, 1999
23. Efendiev R, Krmar RT, Ogimoto G, Zwiller J, Tripodi G, Katz AI, Bianchi G, Pedemonte CH, Bertorello AM: Hypertension-linked mutation in the adducin alpha-subunit leads to higher AP2-mu2 phosphorylation and impaired Na+,K+-ATPase trafficking in response to GPCR signals and intracellular sodium. Circ Res 95: 1100-1108, 2004
24. Manunta P, Cusi D, Barlassina C, Righetti M, Lanzani C, D'Amico M, Buzzi L, Citterio L, Stella P, Rivera R, Bianchi G: Alpha-adducin polymorphisms and renal sodium handling in essential hypertensive patients. Kidney Int 53: 1471-1478, 1998
25. Manunta P, Burnier M, D'Amico M, Buzzi L, Maillard M, Barlassina C, Lanella G, Cusi D, Bianchi G: Adducin polymorphism affects renal proximal tubule reabsorption in hypertension. Hypertension 33: 694-697, 1999
26. Bianchi G, Ferrari P, Staessen JA: Adducin polymorphism: Detection and impact on hypertension and related disorders. Hypertension 45: 331-340, 2005
27. Grant FD, Romero JR, Jeunemaitre X, Hunt SC, Hopkins PN, Hollenberg NH, Williams GH: Low-renin hypertension, altered sodium homeostasis, and an alpha-adducin polymorphism. Hypertension 39: 191-196, 2002
28. Williams GH: Genetic factors associated with volume-sensitive hypertension. Mol Cell Endocrinol 217: 41-44, 2004
29. Lanzani C, Citterio L, Jankaricova M, Sciarrone MT, Barlassina C, Fattori S, Messaggio E, Di Serio C, Zagato L, Cusi D, Hamlyn JM, Stella A, Bianchi G, Manunta P: Role of the adducin family genes in human essential hypertension. J Hypertens 23: 543-549, 2005
30. Cwynar M, Staessen JA, Ticha M, Nawrot T, Citerio L, Kuznetsova T, Wojciechowska W, Stolarz K, Filipovsky J, Kawecka-Jaszcz K, Grodzicki T, Struijker-Boudier HA, Thijs L, Van Bortel LM, Bianchi G: Epistatic interaction between alfa and gamma adducing influences peripheral and central pulse pressure in white Europeans. J Hypertens 23: 961-969, 2005
31. Tikhonoff V, Kuznetsova T, Stolarz K, Bianchi G, Casiglia E, Kawecka-Jaszcz K, Nikitin Y, Tizzone L, Wang JG, Staessen JA: Beta-adducin polymorphisms, blood pressure, and sodium excretion in three European populations. Am J Hypertens 16: 840-846, 2003
32. Wang JG, Liu L, Zagato L, Xie J, Fagard R, Jin K, Wang J, Li Y, Bianchi G, Staessen JA, Liu L: Blood pressure in relation to three candidate genes in a Chinese population. J Hypertens 22: 937-944, 2004
33. Busjahn A, Aydin A, von Treuenfels N, Faulhaber HD, Gohlke HR, Knoblauch H, Schuster H, Luft FC: Linkage but lack of association for blood pressure and the alpha-adducin locus in normotensive twins. J Hypertens 17: 1437-1441, 1999
34. Ju Z, Zhang H, Sun K, Song Y, Lu H, Hui R, Huang X: Alpha-adducin gene polymorphism is associated with essential hypertension in Chinese: A case-control family-based study. J Hypertens 21: 1861-1868, 2003
35. Bray MS, Li L, Turner ST, Kardia SL, Boerwinkle E: Association and linkage analysis of the alpha-adducin gene and blood pressure. Am J Hypertens 13: 699-703, 2000
36. Niu T, Xu X, Cordell HJ, Rogus J, Zhou Y, Fang Z, Lindpaintner K: Linkage analysis of candidate genes and gene-gene interactions in Chinese hypertensive sib pairs. Hypertension 33: 1332-1337, 1999
37. Chu SL, Zhu DL, Xiong MM, Wang GL, Zhang WZ, Zhou HF, Shen D, Gao PJ, Zhan YM, Jin L: Linkage analysis of twelve candidate gene loci regulating water and sodium metabolism and membrane ion transport in essential hypertension. Hypertens Res 25: 635-639, 2002
38. He X, Wang G, Huang W, Ding-Liang Z: Linkage analysis of five candidate genes and essential hypertension in 106 Chinese nuclear families. J Hum Hypertens 17: 69-72, 2003
39. The International HapMap Consortium: A haplotype map of the human genome. Nature 437: 1299-1320, 2005
40. Psaty BM, Doggen C, Vos HL, Vandenbroucke JP, Rosendaal FR: Association of the alpha-adducin polymorphism with blood pressure and risk of myocardial infarction. J Hum Hypertens 14: 95-97, 2000
41. Psaty BM, Smith NL, Heckbert SR, Vos HL, Lemaitre RN, Reiner AP, Siscovick DS, Bis J, Lumley T, Longstreth WT Jr, Rosendaal FR: Diuretic therapy, the alpha-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension. JAMA 287: 1680-1689, 2002
42. Morrison AC, Bray MS, Folsom AR, Boerwinkle E: ADD1 460W allele associated with cardiovascular disease in hypertensive individuals. Hypertension 39: 1053-1057, 2002
43. Li Y, Thijs L, Kuznetsova T, Zagato L, Struijker-Boudier H, Bianchi G, Staessen JA: Cardiovascular risk in relation to alpha-adducin Gly460Trp polymorphism and systolic pressure: A prospective population study. Hypertension 46: 527-532, 2005
44. Grobbee DE, Kroon AA, de Leeuw PW, Peeters PHM, Bots ML, van der Schouw YT: Alpha-Adducin Gly460Trp polymorphism increases the risk of stroke in hypertensive women. Abstract presented at the 15th European Meeting on Hypertension; June 17-21, 2005; Milan, Italy
45. Glorioso N, Manunta P, Filigheddu F, Troffa C, Stella P, Barlassina C, Lombardi C, Soro A, Dettori F, Parpaglia PP, Alibrandi MT, Cusi D, Bianchi G: The role of alpha-adducin polymorphism in blood pressure and sodium handling regulation may not be excluded by a negative association study. Hypertension 34: 649-654, 1999
46. Sciarrone MT, Stella P, Barlassina C, Manunta P, Lanzani C, Bianchi G, Cusi D: ACE and alpha-adducin polymorphism as markers of individual response to diuretic therapy. Hypertension 41: 398-403, 2003
47. Turner ST, Chapman AB, Schwartz GL, Boerwinkle E: Effects of endothelial nitric oxide synthase, alpha-adducin, and other candidate gene polymorphisms on blood pressure response to hydrochlorothiazide. Am J Hypertens 16: 834-839, 2003
48. Swart S, Bing RF, Swales JD, Thurston H: Plasma renin in long-term diuretic treatment of hypertensive: Effect of discontinuation and restarting therapy. Clin Sci 63: 121-125, 1982